Cancer Research Breakthroughs Archives - Page 2 of 6 - NFCR

Cancer Research Breakthroughs

Liquid Biopsy Advances: Capturing Metastatic Cancer Cells

A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientists supported by the National Foundation for Cancer Research since 2003, the business card-sized…...

Read more

Dr. Doug Lowy on the Future of Cancer Research

Dr. Lowy, in collaboration with Dr. John Schiller, has been awarded the 2018 Szent-Györgyi prize for Progress in Cancer Research for their development of a preventive vaccine for human papilloma virus, which is the leading cause of cervical cancer cases. See why Dr. Lowy thinks that the problems with cancer…...

Read more

Artemisinin Therapies: Connecting the Dots

You wouldn’t think it, but the science cannot be denied: One of the newest and most promising drug candidates for cancer was actually developed all the way back in 1972. For malaria. “There were some hints in the literature, but we were totally ignorant,” admits Curt Civin, M.D., whose work…...

Read more

Pediatric Cancer Drug Has 93 Percent Effectiveness

A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for not just one cancer, but many. Hailed by the U.S. Food and Drug Administration as a “breakthrough therapy,” larotrectinib targets a…...

Read more

The Role of Micronutrients in Battling Cancer

It was largely the work of Helmut Sies, M.D., the esteemed pioneer of oxidative stress whom the National Foundation for Cancer Research (NFCR) supported from 1983 to 2016, that brought the role of micronutrients, including flavonoids, into scientific focus....

Read more

Hot and Cold: A New Pancreatic Cancer Treatment?

It is established medical fact that either heating or freezing a cancer cell can kill it, but a new treatment out of the State University of New York at Binghamton (AKA Binghamton University) for pancreatic cancer involves using both, with the result being more of a whole tumor being destroyed.…...

Read more

Worldwide burden of cancer attributable to diabetes and high body-mass index

The International Agency for Research on Cancer (IARC) and the World Cancer Research Fund (WCRF) have concluded that there is a causal association between diabetes and high BMI and several types of cancer.  As the prevalence of  these cancer risk factors increases, clinical and public health efforts should focus on identifying…...

Read more